Lesson B6 - Pharmacology Flashcards

1
Q

The psychoses are among the most severe psychiatric disorders. People with this disorder suffer
from a

A

marked impairment of behaviour.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

There are at least two subdivisions of psychosis

A

: (a) organic, and (b) functional (of unknown cause)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Organic psychoses are associated with

A

causes that are understood and definable e.g. toxic,

metabolic or neuropathological changes. T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Functional (of unknown cause) psychoses are characterized by

A

retention of orientation and
memory in the presence of severely disordered thought or reasoning, emotion and behaviour.
The functional psychoses include schizophrenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Affective disorders are characterized primarily by a

A

change in emotion or mood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Affective disorders consist mainly of a single

disorder of mood - either mania or

A

severe depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Mania is characterized by elation,

hyperactivity, and uncontrollable thought and speech. An individual suffering from

A

m depression

has feelings of intense sadness and self-disapproval, and physical and mental slowing.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

An individual suffering from manic-depressive disorder exhibits

A

alternating periods of mania

and depression.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

In contrast to the psychoses, individuals suffering from neuroses retain the ability to

A

comprehend reality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Neuroses - . The symptoms may involve mood
changes such as anxiety, panic or restlessness, and a feeling of being ill at ease. Individuals may
exhibit limited

A

abnormalities of thought such as obsessions or irrational fears or of behaviour
such as rituals or compulsions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Symptoms of

schizophrenia are classified as

A

positive and negative.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

The positive symptoms include delusions

and hallucinations, bizarre behaviour, lack of logic and incoherence while

A

apathy, social

withdrawal and loss of motivation are among the symptoms referred to as negative symptoms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

The theory of schizophrenia – the dopamine hypothesis is the most fully developed theory of
schizophrenia, but recent evidence indicates

A

that other neurotransmitters such as serotonin,

gamma-aminobutyric acid, and glutamic acid may be involved in schizophrenia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

schizophrenia =

A

excessive dopaminergic activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Two other transmitters have also been postulated to play a role in schizophrenia

A

serotonin and glutamate.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Most of the “typical” antipsychotic drugs are

A

potent blockers of postsynaptic dopamine

receptors in the CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Drugs that increase dopaminergic activity such as levodopa (a precursor of dopamine),
amphetamines (releasers of dopamine), or apomorphine (a direct dopamine receptor
agonist) either

A

aggravate schizophrenia or induce it in some individuals.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Using a technique known as positron emission tomography (PET), dopamine receptor
density has been shown to be

A

higher in schizophrenic than in non-schizophrenic persons.

19
Q

Antipsychotic action can be explained by antagonism of dopamine receptors in the

A

mesolimbic and mesofrontal systems of the brain (meso = middle)

20
Q

Extrapyramidal movement disorders: Antagonism of dopamine receptors in the

A

nigrostriatal system.

21
Q

Extrapyramidal movement disorders: Endocrine effects: Dopamine in the hypothalamus exerts a tonic inhibitory effect on prolactin
release from

A

m the pituitary gland

22
Q

Blockade of histamine receptors:

Adverse effects:

A

Sedation, drowsiness, and weight gain

23
Q

Blockade of α-adrenoceptors:

Adverse effects:

A
Postural hypotension (hypotension when assuming an erect position), 
dizziness, reflex tachycardia
24
Q

Clozapine is a very useful addition to our therapeutic armamentarium of antipsychotic drugs
because it relieves both the positive and negative symptoms of schizophrenia. Since patients
have fewer

A

extrapyramidal side effects when taking clozapine, compliance is better with
clozapine than with older antipsychotics

25
Q

Clozapine can cause

A

granulocytopenia (a decrease in

the number of white blood cells)

26
Q

Lithium carbonate is a mood-stabilizing agent which is used to prevent mood swings in patients
with

A

manic-depressive disorder. It is also used to treat mania.

27
Q

The mechanism of action of lithium has not been resolved. Three possibilities are under
investigation:

A
  1. Effect on electrolytes and ion transport.
  2. Effects on neurotransmitters and the release of neurotransmitters.
  3. Effect on second messengers that mediate transmitter action.
28
Q

Lithium is the drug of choice for long-term maintenance to prevent

A

both manic and depressive

episodes in patients with manic-depressive disorder

29
Q

The safety and efficacy of lithium is enhanced by

A

monitoring serum lithium concentration

30
Q

Antidepressant Agents-There are several

types of depression and depressions are classified as follows:

A

Reactive (secondary) depression. This is the most common type and accounts for over
60% of all depressions.

Major depression (endogenous). In major depression there are characteristic disturbances 
of major body rhythms of sleep, hunger and appetite

Depression associated with manic-depressive disorder.

31
Q

The major theory which has been proposed to explain major depression is known as the amine
hypothesis

A

Animal studies showed that reserpine inhibited reuptake and storage of serotonin and norepinephrine in the vesicles of presynaptic nerve endings. As a result, there was
a depletion of amine stores in these vesicles and amine-dependent neurotransmission would be
diminished. Since reserpine induced depression and depleted stores of amine neurotransmitters,
it was reasoned that depression might be associated with decreased functional amine dependent
neurotransmission.

32
Q

The amine hypothesis does not explain all the effects of antidepressants in depression. The
neurotrophic hypothesis suggests that depression is associated with

A

reduced neurotrophic
(growth and inter-connectivity of neurons) support and that antidepressants stimulate
neurogenesis and synaptic connectivity in cortical areas.

33
Q

Tricyclic antidepressants: Imipramine is a member of this class of antidepressants which share a

A

three-ring nucleus

34
Q

Second-generation (atypical) antidepressants: Bupropion and amoxapine, introduced after
1980, are structurally unrelated to the tricyclic antidepressants and were introduced in an attempt
to

A

have available antidepressants with less adverse effects.

35
Q

Selective serotonin reuptake inhibitors (SSRI’s):

A

The tricyclic antidepressants have anticholinergic
(muscarinic), antiadrenergic (alpha), and antihistaminic actions which do not contribute to their efficacy but do contribute to their toxicity. The SSRI’s, in contrast, have much less effect on the
autonomic nervous system and therefore have less toxicity.

36
Q

Drugs that block Serotonin and norepinephrine uptake: Drugs such as venlafaxine block
transporters for both serotonin and norepinephrine and have an

A

advantage over the tricyclic

antidepressants due to their better safety profiles. (Less adverse effects).

37
Q

Monoamine oxide (MAO) inhibitors: There are two monoamine oxidase (MAO) enzymes,
designated MAO-A and MAO-B. MAO-A is the enzyme primarily responsible for metabolism
of

A

norepinephrine, serotonin and tyramine.

38
Q

MAO-B is more selective for dopamine metabolism.

Selective blockade of MAO-A is therefore

A

considered more selective for therapy of depression

39
Q

Phenelzine and tranylcypromine are non-selective inhibitors of MAO-A and MAO-B. They
combine irreversibly with the enzymes and therefore have a

A

prolonged duration of action.

40
Q

Moclobemide

is a new

A

short-acting reversible inhibitor of MAO-A and 90% of the drug appears in urine within
12 hours of administration.

41
Q

In the past, a tricyclic antidepressant such as imipramine has been considered as the drug of first
choice for treatment of

A

depression

42
Q

In recent years, an SSRI such as fluoxetine (Prozac) is often
used instead, especially for patients with

A

major depressive disorder anxiety disorder

43
Q

SSRI’s: The SSRI’s cause nausea, headache, nervousness, and insomnia more commonly than
the

A

tricyclic antidepressants

44
Q

MAO inhibitors: If MAO inhibitors are prescribed, patients must be warned that they interact
with dangerous consequences with many other drugs, both prescription and over-the-counter,
and with

A

tyramine-containing food